Amdocs (DOX) Projected to Post Quarterly Earnings on Tuesday

Amdocs (NASDAQ:DOX - Get Free Report) is expected to post its quarterly earnings results after the market closes on Tuesday, February 4th. Analysts expect Amdocs to post earnings of $1.64 per share and revenue of $1.11 billion for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

Amdocs Stock Up 0.0 %

Amdocs stock traded up $0.03 during midday trading on Tuesday, hitting $86.74. 530,801 shares of the stock were exchanged, compared to its average volume of 529,012. Amdocs has a 52-week low of $74.41 and a 52-week high of $94.04. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. The business's 50-day moving average price is $85.69 and its 200-day moving average price is $86.15. The stock has a market capitalization of $9.79 billion, a price-to-earnings ratio of 20.46, a price-to-earnings-growth ratio of 1.42 and a beta of 0.71.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a $0.479 dividend. This represents a $1.92 annualized dividend and a dividend yield of 2.21%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs's dividend payout ratio is presently 45.28%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, January 14th. Barclays cut their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. Stifel Nicolaus began coverage on shares of Amdocs in a report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price objective for the company. Finally, Oppenheimer boosted their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.